Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.2 USD | +6.67% | +4.92% | -53.33% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 30.37M | Capitalization | 24.97M |
---|---|---|---|---|---|
Net income 2024 * | -19M | Net income 2025 * | 9M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.82 x |
P/E ratio 2024 * |
-0.84
x | P/E ratio 2025 * |
-1.75
x | Employees | 63 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.01% |
Latest transcript on Evaxion Biotech A/S
1 day | +6.67% | ||
1 week | +5.61% | ||
Current month | -11.11% | ||
1 month | -11.11% | ||
3 months | -54.29% | ||
6 months | -61.86% | ||
Current year | -53.33% |
Managers | Title | Age | Since |
---|---|---|---|
Andreas Mattsson
FOU | Founder | - | 08-08-10 |
Niels Møller
FOU | Founder | 46 | 08-08-10 |
Chief Executive Officer | 52 | 23-08-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 54 | 17-12-31 | |
Lars Holtug
BRD | Director/Board Member | 66 | 21-05-24 |
Marianne Søgaard
CHM | Chairman | 56 | 17-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 3.2 | +6.67% | 17,197 |
24-03-27 | 3 | -4.15% | 25,627 |
24-03-26 | 3.13 | +0.97% | 9,983 |
24-03-25 | 3.1 | +1.64% | 15,588 |
24-03-22 | 3.05 | 0.00% | 14,565 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.33% | 23.41M | |
+9.30% | 45.97B | |
+52.73% | 43.93B | |
+7.15% | 42.34B | |
-8.78% | 28.27B | |
+18.68% | 27.18B | |
-21.92% | 19.44B | |
+14.62% | 13.83B | |
+31.85% | 12.4B | |
+4.47% | 11.45B |